Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: A high proportion of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia die within a few days of the onset of infection. However, predictive factors for early mortality (EM) have barely been examined. The aim of this study was to determine the predictive factors for EM in patients with MRSA bacteraemia. METHODS: All episodes of MRSA bacteraemia were prospectively followed in 21 Spanish hospitals from June 2008 to December 2009. Epidemiology, clinical data, therapy and outcome were recorded. All MRSA strains were analysed in a central laboratory. Mortality was defined as death from any cause occurring in the 30 days after the onset of MRSA bacteraemia. EM was defined as patients who died within the first 2 days, and late mortality (LM) for patients who died after this period. Multivariate analyses were performed by using logistic regression models. RESULTS: A total of 579 episodes were recorded. Mortality was observed in 179 patients (31%): it was early in 49 (8.5%) patients and late in 130 (22.5%). Independent risk factors for EM were [OR (95% CI)] initial Pitt score >3 [3.99 (1.72-3.24)], previous rapid fatal disease [3.67 (1.32-10.24)], source of infection lower respiratory tract or unknown [3.76 (1.31-10.83) and 2.83 (1.11-7.21)], non-nosocomial acquisition [2.59 (1.16-5.77)] and inappropriate initial antibiotic therapy [3.59 (1.63-7.89)]. When predictive factors for EM and LM were compared, inappropriate initial antibiotic therapy was the only distinctive predictor of EM, while endocarditis and lower respiratory tract sources both predicted LM. CONCLUSIONS: In our large cohort of patients several factors were related to EM, but the only distinctive predictor of EM was inappropriate initial antibiotic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [143]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2008) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Update to the Multiplex PCR Strategy for Assignment of mec Element Types in Staphylococcus aureus
Milheiriço, C., Oliveira, D. C., & de Lencastre, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00275-07 · Cited by 490
Gram-Negative Bacteremia: II. Clinical, Laboratory, and Therapeutic Observations
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240038007 · Cited by 384
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
Chow, J. W., & Yu, V. L. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00060-0 · Cited by 320
Chung, M., De Lencastre, H., Matthews, P., Tomasz, A., MULTILABORATORY PROJECT COLLABORATORS—INGER ADAMSSON, De Sousa, M. A., Camou, T., Cocuzza, C., Corso, A., Couto, I., et al. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.189 · Cited by 293
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia
Soriano, A., Martinez, J. A., Mensa, J., Marco, F., Almela, M., Moreno-Martinez, A., Sanchez, F., Munoz, I., Jimenez de Anta, M. T., & Soriano, E. (2000) · Clinical Infectious Diseases · doi:10.1086/313650 · Cited by 256
Shopsin, B., Mathema, B., Alcabes, P., Said-Salim, B., Lina, G., Matsuka, A., Martinez, J., & Kreiswirth, B. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.456-459.2003 · Cited by 235
Self-citationHolmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228
Paul, M., Kariv, G., Goldberg, E., Raskin, M., Shaked, H., Hazzan, R., Samra, Z., Paghis, D., Bishara, J., & Leibovici, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq373 · Cited by 224
Lodise, T. P., & McKinnon, P. S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.007 · Cited by 199
McGregor, J. C., Rich, S. E., Harris, A. D., Perencevich, E. N., Osih, R., Lodise, T. P., Miller, R. R., & Furuno, J. P. (2007) · Clinical Infectious Diseases · doi:10.1086/519283 · Cited by 194
Staphylococcus aureus Bacteremia: Predictors of 30-Day Mortality in a Large Cohort
Mylotte, J. M., & Tayara, A. (2000) · Clinical Infectious Diseases · doi:10.1086/317421 · Cited by 190
Kaech, C., Elzi, L., Sendi, P., Frei, R., Laifer, G., Bassetti, S., & Flückiger, U. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01359.x · Cited by 174
Harris, A. D., Samore, M. H., Lipsitch, M., Kaye, K. S., Perencevich, E., & Carmeli, Y. (2002) · Clinical Infectious Diseases · doi:10.1086/340533 · Cited by 171
Benfield, T., Espersen, F., Frimodt-Møller, N., Jensen, A. G., Larsen, A. R., Pallesen, L. V., Skov, R., Westh, H., & Skinhøj, P. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01589.x · Cited by 161
Fowler, V. G., Nelson, C. L., McIntyre, L. M., Kreiswirth, B. N., Monk, A., Archer, G. L., Federspiel, J., Naidich, S., Remortel, B., Rude, T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520088 · Cited by 153
Roghmann, M.-C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.1001 · Cited by 130
Tacconelli, E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh107 · Cited by 127
Predicting Risk for Death from MRSA Bacteremia1
Pastagia, M., Kleinman, L. C., Lacerda de la Cruz, E. G., & Jenkins, S. G. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1807.101371 · Cited by 95
Lalani, T., Federspiel, J. J., Boucher, H. W., Rude, T. H., Bae, I.-G., Rybak, M. J., Tonthat, G. T., Corey, G. R., Stryjewski, M. E., Sakoulas, G., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00905-08 · Cited by 77
Marchaim, D., Kaye, K. S., Fowler, V. G., Anderson, D. J., Chawla, V., Golan, Y., Karchmer, A. W., & Carmeli, Y. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02934.x · Cited by 65
Rodríguez‐Baño, J., Millán, A. B., Domínguez, M. Á., Borraz, C., González, M. P., Almirante, B., Cercenado, E., Padilla, B., & Pujol, M. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.11.003 · Cited by 62
Self-citationFang, C.-T., Shau, W.-Y., Hsueh, P.-R., Chen, Y.-C., Wang, J.-T., Hung, C.-C., Huang, L. Y. L., & Chang, S.-C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl006 · Cited by 53
Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004–2005
Lamagni, T. L., Potz, N. A. C., Powell, D., Pebody, R. G., Wilson, J. A., & Duckworth, G. J. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.07.015 · Cited by 52
Gasch, O., Ayats, J., Domínguez, M. Á., Tubau, F., Liñares, J., Peña, C., Grau, I., Pallarés, R., Gudiol, F., Ariza, J., et al. (2011) · Medicine · doi:10.1097/md.0b013e31822f0b54 · Cited by 51
Self-citationRojas, L., Bunsow, E., Munoz, P., Cercenado, E., Rodríguez‐Créixems, M., & Bouza, E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks128 · Cited by 49
Lin, S.-H., Liao, W.-H., Lai, C.-C., Liao, C.-H., Tan, C.-K., Wang, C.-Y., Huang, Y.-T., & Hsueh, P.-R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq188 · Cited by 48
Manzur, A., Vidal, M., Pujol, M., Cisnal, M., Hornero, A., Aumatell, C. M., Peña, C., Gudiol, F., & Ariza, J. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.03.015 · Cited by 46
Self-citationLibert, M., Elkholti, M., Massaut, J., Karmali, R., Mascart, G., & Cherifi, S. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.08.021 · Cited by 41
Liao, C.-H., Chen, S.-Y., Huang, Y.-T., & Hsueh, P.-R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.04.011 · Cited by 40
Honda, H., Doern, C. D., Michael-Dunne, W., & Warren, D. K. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-335 · Cited by 36
Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia
Albur, M., Bowker, K. E., Weir, I. S., & MacGowan, A. P. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1310-2 · Cited by 28
What Is Inadequate Antibacterial Therapy?
Moellering, R. C. (2009) · Clinical Infectious Diseases · doi:10.1086/605556 · Cited by 7
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Geisinger, E., & Isberg, R. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw402 · Cited by 197
“This study provides a potential connection between inappropriate empiric antibiotic treatment of nosocomial MRSA infections and worsened clinical outcomes [89].”
BackgroundHumphreys, H., Fitzpatick, F., & Harvey, B. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ576 · Cited by 156
Variations in Organism-Specific Severe Sepsis Mortality in the United States: 1999–2008*
Ani, C., Farshidpanah, S., Bellinghausen Stewart, A., & Nguyen, H. B. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000555 · Cited by 84
Metadata
- Authors
- Gasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Lepe, J. A., Lagarde, M., Ruiz de Gopegui, E., Martinez, J. A., Montejo, M., Torre-Cisneros, J., Arnaiz, A., Goenaga, M. A., Benito, N., Rodriguez-Bano, J., Pujol, M., & Groups, O. B. O. T. R. S.
- Affiliations
- Bellvitge University Hospital (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital de Cruces (ES)
- Hospital de Sant Pau (ES)
- Corresponding author
- Gasch, O.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-12
- Volume
- 68
- Issue
- 6
- Pages
- 1423-1430
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2157744708
- Cited by
- 52
- References
- 47
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 8 · 2016: 4 · 2015: 8 · 2014: 4 · 2013: 5
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Instituto de Salud Carlos III (RD06/0008, FIS 08/0335)
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, bacteremia, early mortality, late mortality, risk factors, Pitt score, endocarditis, lower respiratory tract infection
- MeSH terms
- Age Factors, Aged, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Predictive Value of Tests, Risk Factors, Sex Factors, Staphylococcal Infections, Cohort Studies, Logistic Models, Bacteremia, Treatment Outcome, Drug Resistance, Bacterial, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.